These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1434142)

  • 1. Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
    Sakamoto O; Mori H; Kitaichi K; Koda A; Kato T
    Jpn J Pharmacol; 1992 Aug; 59(4):469-76. PubMed ID: 1434142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel derivatives of 5-fluorouridine and 5-fluorouracil having potent antitumor and lower immunosuppressive activities.
    Mori H; Sakamoto O; Kitaichi K; Koda A; Kita J
    Jpn J Pharmacol; 1992 Mar; 58(3):269-82. PubMed ID: 1513076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21: antitumor activity and effect on humoral immune response in mice.
    Mori H; Nakayama K; Maeda D; Nagai H; Koda A; Kita J; Kaku Y
    Cancer Chemother Pharmacol; 1994; 34(3):216-24. PubMed ID: 8004754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel low immunosuppressive derivatives of the antitumor drug fluoropyrimidine, UK-21 and UK-25: effect on delayed type hypersensitivity and tumor immunity.
    Sakamoto O; Mori H; Kitaichi K; Koda A
    Jpn J Pharmacol; 1993 Mar; 61(3):209-20. PubMed ID: 8483298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible cytotoxic effect of a novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21.
    Mori H; Nakayama K; Ishida R; Ito S; Nagai H; Koda A
    Anticancer Drugs; 1997 Jun; 8(5):482-8. PubMed ID: 9215612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of 1-alkoxycarbonylalkylcarbamoyl-5-fluorouracil derivatives by oral administration.
    Iigo M; Hoshi A; Inomata M; Ando N; Kuretani K
    J Pharmacobiodyn; 1981 Mar; 4(3):203-10. PubMed ID: 7252769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
    Fujimoto S; Wang Y; Inoue K; Ogawa M
    Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
    Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
    Kobayashi M; Natsume T; Tamaoki S; Watanabe J; Asano H; Mikami T; Miyasaka K; Miyazaki K; Gondo M; Sakakibara K; Tsukagoshi S
    Jpn J Cancer Res; 1997 Mar; 88(3):316-27. PubMed ID: 9140117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
    Waud WR; Plowman J; Harrison SD; Dykes DJ; Anderson WK; Griswold DP
    Cancer Chemother Pharmacol; 1992; 30(4):261-6. PubMed ID: 1322803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.
    Ishitsuka H; Miwa M; Takemoto K; Fukuoka K; Itoga A; Maruyama HB
    Gan; 1980 Feb; 71(1):112-23. PubMed ID: 6445847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine.
    Hartmann HR; Bollag W
    Med Oncol Tumor Pharmacother; 1986; 3(2):111-8. PubMed ID: 2943952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor activities of orally administered 4-carbamoylimidazolium-5-olate (SM-108)].
    Nakamura M; Fukui M; Morisada S; Inaba M; Tsukagoshi S; Sakurai Y
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2030-6. PubMed ID: 4051519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
    Fujimoto S
    Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor effect of a benzoylphenylurea derivative HO-221].
    Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2353-9. PubMed ID: 2260871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30.
    Rose WC; Basler GA; Trail PA; Saulnier M; Crosswell AR; Casazza AM
    Invest New Drugs; 1990; 8 Suppl 1():S25-32. PubMed ID: 2380014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.